These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7780867)

  • 21. Long term effects of thrombolytic therapy in acute myocardial infarction.
    Shah LS
    J Assoc Physicians India; 1994 Jan; 42(1):9-11. PubMed ID: 7836276
    [No Abstract]   [Full Text] [Related]  

  • 22. Criteria for selection of older patients for thrombolytic therapy.
    Brockington CD; Lyden PD
    Clin Geriatr Med; 1999 Nov; 15(4):721-39. PubMed ID: 10499932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue plasminogen activator does not benefit most eligible patients with stroke.
    Lansberg MG; Schwartz NE
    Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bolus fibrinolytic therapy in acute myocardial infarction].
    Pinelli G; Urbinati S
    Ital Heart J Suppl; 2001 Dec; 2(12):1360-2. PubMed ID: 11838360
    [No Abstract]   [Full Text] [Related]  

  • 25. Is there an optimal thrombolytic regimen?
    Collen D
    Coron Artery Dis; 1994 Apr; 5(4):287-91. PubMed ID: 8044339
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolytic treatment for elderly patients with acute myocardial infarction.
    Estess JM; Topol EJ
    Heart; 2002 Apr; 87(4):308-11. PubMed ID: 11906993
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiplatelet and antithrombin therapy.
    Fernández-Ortiz A; Jang IK; Fuster V
    Coron Artery Dis; 1994 Apr; 5(4):297-305. PubMed ID: 8044341
    [No Abstract]   [Full Text] [Related]  

  • 28. 4.5 hours: the new time window for tissue plasminogen activator in stroke.
    Davis SM; Donnan GA
    Stroke; 2009 Jun; 40(6):2266-7. PubMed ID: 19407232
    [No Abstract]   [Full Text] [Related]  

  • 29. Tissue-type plasminogen activator: a new fibrinolytic agent.
    Milligan KS
    Heart Lung; 1987 Jan; 16(1):69-74. PubMed ID: 3098703
    [No Abstract]   [Full Text] [Related]  

  • 30. Tissue-plasminogen activator: a new drug in reperfusion therapy (continuing education credit).
    Strauss E; Rudy EB
    Crit Care Nurse; 1986; 6(3):30-5, 38-43. PubMed ID: 3089687
    [No Abstract]   [Full Text] [Related]  

  • 31. The place of tenecteplase in management of STEMI.
    Chopra HK
    Indian Heart J; 2009; 61(5):408-9. PubMed ID: 20635752
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical pharmacology and therapeutic aspects of thrombolytic agents.
    Fears R
    Pharmacol Rev; 1990 Sep; 42(3):201-22. PubMed ID: 2120714
    [No Abstract]   [Full Text] [Related]  

  • 33. Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial.
    Armstrong PW; Westerhout CM; Van de Werf F; Califf RM; Welsh RC; Wilcox RG; Bakal JA
    Am Heart J; 2011 May; 161(5):848-54. PubMed ID: 21570513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy.
    Califf RM; Stump D; Topol EJ; Mark DB
    Am Heart J; 1999 May; 137(5):S90-3. PubMed ID: 10220606
    [No Abstract]   [Full Text] [Related]  

  • 35. La différence. Long-term benefit of one thrombolytic over another.
    Roberts R
    Circulation; 1996 Sep; 94(6):1203-5. PubMed ID: 8822968
    [No Abstract]   [Full Text] [Related]  

  • 36. New clot busters threaten Genentech's tPA.
    Davidson S
    Nat Biotechnol; 1997 May; 15(5):405. PubMed ID: 9131608
    [No Abstract]   [Full Text] [Related]  

  • 37. Laboratory and clinical experience with recombinant plasminogen activator.
    Builder SE; Grossbard E
    Prog Clin Biol Res; 1986; 211():303-13. PubMed ID: 3083430
    [No Abstract]   [Full Text] [Related]  

  • 38. ER TIMI-19: testing the reality of prehospital thrombolysis.
    Cannon CP; Sayah AJ; Walls RM
    J Emerg Med; 2000 Oct; 19(3 Suppl):21S-25S. PubMed ID: 11050380
    [No Abstract]   [Full Text] [Related]  

  • 39. Pre-hospital thrombolysis in Alta Irpinia: work in progress.
    Bellizzi G; Landi RS; Bianchini G; Dragonetti C; Guarino P; Lo Conte C; Manganelli G; Pellecchia V; Sicignano M; Santamaria A; Citro R; Carbone GL; Bossone E
    Minerva Cardioangiol; 2007 Dec; 55(6):845-6. PubMed ID: 18091651
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of tenecteplase in acute myocardial infarction.
    Iavelov IS
    Kardiologiia; 2007; 47(1):37-46. PubMed ID: 17431964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.